Key result
Short-term maternal use of diclofenac sodium was associated with premature closure of the ductus arteriosus, leading to severe pulmonary hypertension and right-sided hypertrophic cardiomyopathy in a neonate.
Why the study?
Does maternal diclofenac sodium ingestion cause severe neonatal pulmonary hypertension?
Case Report (n=1)
Does maternal diclofenac sodium ingestion cause severe neonatal pulmonary hypertension?
Maternal ingestion of diclofenac sodium should be avoided during pregnancy due to the risk of premature closure of the ductus arteriosus and subsequent severe neonatal pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
This case supports possible diclofenac–neonatal pulmonary hypertension link; hypothesis-generating and does not yet change practice.
We describe a case of severe pulmonary hypertension and transient right-sided hypertrophic cardiomyopathy in a neonate, caused by premature closure of ductus arteriosus after short-term maternal use of diclofenac sodium (Voltaren). In view of this associated complication, diclofenac sodium should be avoided during pregnancy. In addition, maternal diclofenac sodium ingestion should be suspected if a newborn develops severe pulmonary hypertension and/or right-sided hypertrophic cardiomyoptathy with closed ductus arteriosus.
No takes yet. Share an insight, caveat, or question.
Siu et al. (2004) conducted a case report in Severe pulmonary hypertension and transient right-sided hypertrophic cardiomyopathy (n=1). Maternal diclofenac sodium (Voltaren) ingestion was evaluated on Severe pulmonary hypertension and transient right-sided hypertrophic cardiomyopathy with premature closure of ductus arteriosus. Short-term maternal use of diclofenac sodium was associated with premature closure of the ductus arteriosus, leading to severe pulmonary hypertension and right-sided hypertrophic cardiomyopathy in a neonate.
Synapse has enriched 10 related papers. Consider them for comparative context: